-+ 0.00%
-+ 0.00%
-+ 0.00%

INTELLIA THERAPEUTICS TO REPORT TOPLINE DATA FROM GLOBAL PHASE 3 HAELO CLINICAL TRIAL OF LONVOGURAN ZICLUMERAN IN HEREDITARY ANGIOEDEMA ON APRIL 27, 2026

Reuters·04/24/2026 20:05:00

Please log in to view news